Nurse Practitioner · Farmington, MO
NPI
1659724946
Since 2016
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1106 Hazel Ln
Farmington, MO, 63640
Phone (573) 756-6751
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
2,343 services
Medicare patients, 2024
144
Average age 71
Drug cost, 2024
$956K
6,230 prescriptions
Company payments, 2025
$1,766
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lisa Mengwasser was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,840 times for 19 patients. In total Lisa Mengwasser billed 2,343 services in 30 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,840 | 19 | $0.10 | $181 |
| 99214 Office E&M - Established | Office | 283 | 136 | $60.67 | $17K |
| 96372 Injection Administration | Office | 42 | 26 | $7.88 | $331 |
| 96160 E&M - Miscellaneous | Office | 19 | 19 | $0.98 | $18.59 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 19 | 19 | $94.33 | $1,792 |
| 99213 Office E&M - Established | Office | 14 | 14 | $33.58 | $470 |
By year: 2022 $28K for 667 services; 2023 $26K for 544 services; 2024 $22K for 2,343 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 12 | 11 | $2.20 | $26.4 |
Medicare prescription drug claims, 2024
In 2024, the drug Lisa Mengwasser prescribed most often to Medicare patients was Atorvastatin Calcium, with 331 prescriptions and refills. In total Lisa Mengwasser wrote 6,230 Medicare prescriptions that cost $956K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 331 | 777 | 86 | $2,125 |
| Levothyroxine Sodium Generic | 245 | 581 | 64 | $1,962 |
| Montelukast Sodium Generic | 241 | 547 | 65 | $1,487 |
| Gabapentin Generic | 212 | 352 | 53 | $3,132 |
| Lisinopril Generic | 198 | 510 | 51 | $788 |
| Omeprazole Generic | 171 | 427 | 50 | $2,108 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 136 | 160 | 41 | $2,456 |
| Trazodone Hcl Generic | 112 | 240 | 28 | $492 |
| Potassium Chloride Generic | 111 | 237 | 29 | $1,313 |
| Furosemide Generic | 102 | 269 | 32 | $313 |
| Losartan Potassium Generic | 97 | 245 | 31 | $509 |
| Fluticasone Propionate Generic | 95 | 163 | 32 | $1,049 |
| Amlodipine Besylate Generic | 92 | 231 | 27 | $316 |
| Farxiga Dapagliflozin Propanediol | 89 | 166 | 24 | $94K |
| Metformin Hcl Er Metformin Hcl | 89 | 192 | 27 | $556 |
Brand drugs: 1,068 claims; generic drugs: 5,104 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lisa Mengwasser $1,766 ($1,766 in general payments such as food, travel and fees) from 27 companies. The largest payer was Abbvie Inc. with $246.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $246 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 10 | $218 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $156 |
| Lilly USA, LLC LLY | 6 | $139 |
| Axsome Therapeutics, Inc. AXSM | 4 | $104 |
| Novo Nordisk Inc NVO | 3 | $94.79 |
| Pfizer Inc. PFE | 4 | $87.87 |
| Aimmune Therapeutics, Inc. | 2 | $82.07 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $78.99 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $73.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.